Teachers Advisors LLC grew its holdings in shares of Masimo Co. (NASDAQ:MASI) by 5.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 366,093 shares of the medical equipment provider’s stock after acquiring an additional 17,404 shares during the quarter. Teachers Advisors LLC owned about 0.71% of Masimo worth $31,045,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the company. Bank of New York Mellon Corp boosted its position in shares of Masimo by 6.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,074,648 shares of the medical equipment provider’s stock valued at $93,021,000 after acquiring an additional 64,882 shares during the last quarter. Old Mutual Global Investors UK Ltd. boosted its position in shares of Masimo by 9.0% during the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 881,000 shares of the medical equipment provider’s stock valued at $74,708,000 after acquiring an additional 72,512 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Masimo by 6.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 851,234 shares of the medical equipment provider’s stock valued at $72,278,000 after acquiring an additional 48,536 shares during the last quarter. Prudential Financial Inc. boosted its position in shares of Masimo by 23.9% during the 3rd quarter. Prudential Financial Inc. now owns 685,268 shares of the medical equipment provider’s stock valued at $59,317,000 after acquiring an additional 132,053 shares during the last quarter. Finally, American Century Companies Inc. boosted its position in shares of Masimo by 23.1% during the 4th quarter. American Century Companies Inc. now owns 587,070 shares of the medical equipment provider’s stock valued at $49,784,000 after acquiring an additional 110,107 shares during the last quarter. Hedge funds and other institutional investors own 82.74% of the company’s stock.
Masimo Co. (MASI) opened at $85.67 on Friday. The firm has a market capitalization of $4,505.27, a PE ratio of 36.30, a P/E/G ratio of 2.29 and a beta of 0.92. Masimo Co. has a 1-year low of $80.69 and a 1-year high of $104.71.
Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $0.72 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.11. The company had revenue of $225.20 million for the quarter, compared to analysts’ expectations of $201.54 million. Masimo had a return on equity of 22.75% and a net margin of 16.49%. Masimo’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period last year, the firm posted $0.46 EPS. analysts anticipate that Masimo Co. will post 2.81 EPS for the current year.
In other Masimo news, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $93.07, for a total value of $186,140.00. Following the transaction, the director now directly owns 68,249 shares of the company’s stock, valued at approximately $6,351,934.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Yongsam Lee sold 10,000 shares of Masimo stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $88.17, for a total value of $881,700.00. Following the completion of the transaction, the executive vice president now directly owns 75,018 shares in the company, valued at $6,614,337.06. The disclosure for this sale can be found here. Insiders sold a total of 24,100 shares of company stock worth $2,186,340 over the last ninety days. Insiders own 16.60% of the company’s stock.
A number of brokerages have recently issued reports on MASI. Piper Jaffray Companies reiterated a “hold” rating and set a $91.00 price target on shares of Masimo in a research report on Thursday, March 1st. Zacks Investment Research cut Masimo from a “buy” rating to a “hold” rating in a report on Wednesday, January 3rd. BidaskClub raised Masimo from a “sell” rating to a “hold” rating in a report on Thursday, March 1st. Finally, Barclays assumed coverage on Masimo in a report on Friday, March 9th. They set an “overweight” rating and a $97.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Masimo presently has an average rating of “Buy” and a consensus target price of $101.00.
COPYRIGHT VIOLATION NOTICE: “Masimo Co. (MASI) Shares Bought by Teachers Advisors LLC” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thelincolnianonline.com/2018/03/23/masimo-co-masi-shares-bought-by-teachers-advisors-llc.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.